Invasive aspergillosis in hematopoietic stem cell transplant recipients: a retrospective analysis

Invasive aspergillosis (IA) currently is an important cause of mortality in subjects undergoing hematopoietic stem cell transplants (HSCT) and is also an important cause of opportunistic respiratory and disseminated infections in other types of immunocompromised patients. We examined the medical rec...

Full description

Bibliographic Details
Main Authors: Viviane Maria Hessel Carvalho-Dias, Caroline Bonamin Santos Sola, Clóvis Arns da Cunha, Sílvia Emiko Shimakura, Ricardo Pasquini, Flávio de Queiroz-Telles
Format: Article
Language:English
Published: Elsevier
Series:Brazilian Journal of Infectious Diseases
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702008000500008&lng=en&tlng=en
_version_ 1828792860146663424
author Viviane Maria Hessel Carvalho-Dias
Caroline Bonamin Santos Sola
Clóvis Arns da Cunha
Sílvia Emiko Shimakura
Ricardo Pasquini
Flávio de Queiroz-Telles
author_facet Viviane Maria Hessel Carvalho-Dias
Caroline Bonamin Santos Sola
Clóvis Arns da Cunha
Sílvia Emiko Shimakura
Ricardo Pasquini
Flávio de Queiroz-Telles
author_sort Viviane Maria Hessel Carvalho-Dias
collection DOAJ
description Invasive aspergillosis (IA) currently is an important cause of mortality in subjects undergoing hematopoietic stem cell transplants (HSCT) and is also an important cause of opportunistic respiratory and disseminated infections in other types of immunocompromised patients. We examined the medical records of 24 cases of proven and probable invasive aspergillosis (IA) at the Hospital de Clinicas of the Federal University of Parana, Brazil, from January 1996 to October 2006. During this period occurred a mean of 2.2 cases per year or 3.0 cases per 100 HSTC transplants. There was a significant relationship between structural changes in the bone marrow transplant (BMT) Unit and the occurrence of IA cases (p=0.034, relative risk (RR) = 2.47). Approximately 83% of the patients died due to invasive fungal infection within 60 days of follow up. Some factors tended to be associated with mortality, but these associations were not significant. These included corticosteroid use, neutropenia (<100 cells/mm³) at diagnosis, patients that needed to change antifungal therapy because of toxicity of the initial first-line regimen and disseminated disease. These factors should be monitored in BMT units to help prevent IA. Physicians should be aware of the risk factors for developing invasive fungal infections and try to reduce or eliminate them. However, once this invasive disease begins, appropriate diagnostic and treatment measures must be implemented as soon as possible in order to prevent the high mortality rates associated with this condition.
first_indexed 2024-12-12T03:17:09Z
format Article
id doaj.art-d789126a6d0147cc958c147f49707203
institution Directory Open Access Journal
issn 1678-4391
language English
last_indexed 2024-12-12T03:17:09Z
publisher Elsevier
record_format Article
series Brazilian Journal of Infectious Diseases
spelling doaj.art-d789126a6d0147cc958c147f497072032022-12-22T00:40:16ZengElsevierBrazilian Journal of Infectious Diseases1678-439112538538910.1590/S1413-86702008000500008S1413-86702008000500008Invasive aspergillosis in hematopoietic stem cell transplant recipients: a retrospective analysisViviane Maria Hessel Carvalho-Dias0Caroline Bonamin Santos Sola1Clóvis Arns da Cunha2Sílvia Emiko Shimakura3Ricardo Pasquini4Flávio de Queiroz-Telles5Universidade Federal do ParanáUniversidade Federal do ParanáUniversidade Federal do ParanáUniversidade Federal do ParanáUniversidade Federal do ParanáUniversidade Federal do ParanáInvasive aspergillosis (IA) currently is an important cause of mortality in subjects undergoing hematopoietic stem cell transplants (HSCT) and is also an important cause of opportunistic respiratory and disseminated infections in other types of immunocompromised patients. We examined the medical records of 24 cases of proven and probable invasive aspergillosis (IA) at the Hospital de Clinicas of the Federal University of Parana, Brazil, from January 1996 to October 2006. During this period occurred a mean of 2.2 cases per year or 3.0 cases per 100 HSTC transplants. There was a significant relationship between structural changes in the bone marrow transplant (BMT) Unit and the occurrence of IA cases (p=0.034, relative risk (RR) = 2.47). Approximately 83% of the patients died due to invasive fungal infection within 60 days of follow up. Some factors tended to be associated with mortality, but these associations were not significant. These included corticosteroid use, neutropenia (<100 cells/mm³) at diagnosis, patients that needed to change antifungal therapy because of toxicity of the initial first-line regimen and disseminated disease. These factors should be monitored in BMT units to help prevent IA. Physicians should be aware of the risk factors for developing invasive fungal infections and try to reduce or eliminate them. However, once this invasive disease begins, appropriate diagnostic and treatment measures must be implemented as soon as possible in order to prevent the high mortality rates associated with this condition.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702008000500008&lng=en&tlng=enInvasive aspergillosistransplant recipientsimmunocompromised
spellingShingle Viviane Maria Hessel Carvalho-Dias
Caroline Bonamin Santos Sola
Clóvis Arns da Cunha
Sílvia Emiko Shimakura
Ricardo Pasquini
Flávio de Queiroz-Telles
Invasive aspergillosis in hematopoietic stem cell transplant recipients: a retrospective analysis
Brazilian Journal of Infectious Diseases
Invasive aspergillosis
transplant recipients
immunocompromised
title Invasive aspergillosis in hematopoietic stem cell transplant recipients: a retrospective analysis
title_full Invasive aspergillosis in hematopoietic stem cell transplant recipients: a retrospective analysis
title_fullStr Invasive aspergillosis in hematopoietic stem cell transplant recipients: a retrospective analysis
title_full_unstemmed Invasive aspergillosis in hematopoietic stem cell transplant recipients: a retrospective analysis
title_short Invasive aspergillosis in hematopoietic stem cell transplant recipients: a retrospective analysis
title_sort invasive aspergillosis in hematopoietic stem cell transplant recipients a retrospective analysis
topic Invasive aspergillosis
transplant recipients
immunocompromised
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702008000500008&lng=en&tlng=en
work_keys_str_mv AT vivianemariahesselcarvalhodias invasiveaspergillosisinhematopoieticstemcelltransplantrecipientsaretrospectiveanalysis
AT carolinebonaminsantossola invasiveaspergillosisinhematopoieticstemcelltransplantrecipientsaretrospectiveanalysis
AT clovisarnsdacunha invasiveaspergillosisinhematopoieticstemcelltransplantrecipientsaretrospectiveanalysis
AT silviaemikoshimakura invasiveaspergillosisinhematopoieticstemcelltransplantrecipientsaretrospectiveanalysis
AT ricardopasquini invasiveaspergillosisinhematopoieticstemcelltransplantrecipientsaretrospectiveanalysis
AT flaviodequeiroztelles invasiveaspergillosisinhematopoieticstemcelltransplantrecipientsaretrospectiveanalysis